ReviewFrontiers in oncology2024

Epigenetic regulation of NKG2D ligand and the rise of NK cell-based immunotherapy for cancer treatment.

Raj Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.